Belpointe Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$615K Sell
5,547
-1,880
-25% -$208K 0.03% 503
2025
Q1
$832K Sell
7,427
-1,100
-13% -$123K 0.04% 390
2024
Q4
$674K Buy
8,527
+4,433
+108% +$350K 0.04% 436
2024
Q3
$343K Sell
4,094
-9,049
-69% -$759K 0.02% 620
2024
Q2
$902K Buy
13,143
+2,137
+19% +$147K 0.06% 300
2024
Q1
$806K Buy
11,006
+558
+5% +$40.9K 0.06% 326
2023
Q4
$846K Sell
10,448
-897
-8% -$72.7K 0.07% 245
2023
Q3
$850K Buy
11,345
+3,632
+47% +$272K 0.09% 224
2023
Q2
$594K Sell
7,713
-14,674
-66% -$1.13M 0.06% 268
2023
Q1
$1.86M Sell
22,387
-7,267
-25% -$603K 0.1% 210
2022
Q4
$2.55M Sell
29,654
-6,074
-17% -$521K 0.15% 133
2022
Q3
$2.21M Sell
35,728
-329
-0.9% -$20.3K 0.15% 137
2022
Q2
$2.23M Buy
36,057
+4,194
+13% +$259K 0.15% 145
2022
Q1
$1.89M Buy
31,863
+9,063
+40% +$539K 0.11% 185
2021
Q4
$1.66M Buy
22,800
+2,445
+12% +$178K 0.1% 199
2021
Q3
$1.42M Sell
20,355
-424
-2% -$29.6K 0.1% 225
2021
Q2
$1.43M Buy
20,779
+1,905
+10% +$131K 0.1% 217
2021
Q1
$1.22M Sell
18,874
-3,107
-14% -$201K 0.1% 213
2020
Q4
$1.28M Buy
21,981
+8,598
+64% +$501K 0.12% 212
2020
Q3
$846K Buy
13,383
+242
+2% +$15.3K 0.09% 234
2020
Q2
$1.01M Sell
13,141
-6,219
-32% -$478K 0.13% 167
2020
Q1
$1.45M Buy
19,360
+6,322
+48% +$473K 0.25% 91
2019
Q4
$847K Buy
13,038
+931
+8% +$60.5K 0.11% 208
2019
Q3
$767K Sell
12,107
-2,283
-16% -$145K 0.12% 182
2019
Q2
$972K Buy
14,390
+6,066
+73% +$410K 0.19% 120
2019
Q1
$541K Sell
8,324
-3,577
-30% -$232K 0.11% 155
2018
Q4
$744K Buy
11,901
+4,507
+61% +$282K 0.19% 116
2018
Q3
$571K Buy
7,394
+1,007
+16% +$77.8K 0.09% 223
2018
Q2
$452K Buy
6,387
+1,317
+26% +$93.2K 0.13% 183
2018
Q1
$382K Sell
5,070
-1,016
-17% -$76.6K 0.11% 209
2017
Q4
$436K Buy
6,086
+163
+3% +$11.7K 0.1% 261
2017
Q3
$480K Buy
+5,923
New +$480K 0.11% 199